Literature DB >> 22759545

Increasing burden of methicillin-resistant Staphylococcus aureus hospitalizations at US academic medical centers, 2003-2008.

Michael Z David1, Sofia Medvedev, Samuel F Hohmann, Bernard Ewigman, Robert S Daum.   

Abstract

OBJECTIVE: The incidence of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections in the United States decreased during 2005-2008, but noninvasive community-associated MRSA (CA-MRSA) infections also frequently lead to hospitalization. We estimated the incidence of all MRSA infections among inpatients at US academic medical centers (AMCs) per 1,000 admissions during 2003-2008.
DESIGN: Retrospective cohort study. SETTING AND PARTICIPANTS: Hospitalized patients at 90% of nonprofit US AMCs during 2003-2008.
METHODS: Administrative data on MRSA infections from a hospital discharge database (University HealthSystem Consortium [UHC]) were adjusted for underreporting of the MRSA V09.0 International Classification of Diseases, Ninth Revision, Clinical Modification code and validated using chart reviews for patients with known MRSA infections in 2004-2005, 2006, and 2007.
RESULTS: The mean sensitivity of administrative data for MRSA infections at the University of Chicago Medical Center in three 12-month periods during 2004-2007 was 59.1%. On the basis of estimates of billing data sensitivity from the literature and the University of Chicago Medical Center, the number of MRSA infections per 1,000 hospital discharges at US AMCs increased from 20.9 (range, 11.1-47.7) in 2003 to 41.7 (range, 21.9-94.0) in 2008. At the University of Chicago Medical Center, among infections cultured more than 3 days prior to hospital discharge, CA-MRSA infections were more likely to be captured in the UHC billing-derived data than were healthcare-associated MRSA infections.
CONCLUSIONS: The number of hospital admissions for any MRSA infection per 1,000 hospital admissions overall increased during 2003-2008. Use of unadjusted administrative hospital discharge data or surveillance for invasive disease far underestimates the number of MRSA infections among hospitalized patients.

Entities:  

Mesh:

Year:  2012        PMID: 22759545      PMCID: PMC3682488          DOI: 10.1086/666640

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  21 in total

1.  Identification of hospital-acquired catheter-associated urinary tract infections from Medicare claims: sensitivity and positive predictive value.

Authors:  Chunliu Zhan; Anne Elixhauser; Chesley L Richards; Yun Wang; William B Baine; Michael Pineau; Nancy Verzier; Rebecca Kliman; David Hunt
Journal:  Med Care       Date:  2009-03       Impact factor: 2.983

Review 2.  Administrative coding data and health care-associated infections.

Authors:  Michael A Jhung; Shailen N Banerjee
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

3.  Emergence of the USA300 strain of methicillin-resistant Staphylococcus aureus in a burn-trauma unit.

Authors:  Lucy A Wibbenmeyer; Gerald P Kealey; Barbara A Latenser; Daniel J Diekema; Ingrid M Williams; Stacy L Coffman; Patricia L Winokur; Jennifer S Kroeger; Robert W Lewis; Loreen A Herwaldt
Journal:  J Burn Care Res       Date:  2008 Sep-Oct       Impact factor: 1.845

4.  What is community-associated methicillin-resistant Staphylococcus aureus?

Authors:  Michael Z David; Daniel Glikman; Susan E Crawford; Jie Peng; Kimberly J King; Mark A Hostetler; Susan Boyle-Vavra; Robert S Daum
Journal:  J Infect Dis       Date:  2008-05-01       Impact factor: 5.226

5.  Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit.

Authors:  Thea Chua; Carol L Moore; Mary B Perri; Susan M Donabedian; William Masch; Dora Vager; Susan L Davis; Kaitlin Lulek; Benjamin Zimnicki; Marcus J Zervos
Journal:  J Clin Microbiol       Date:  2008-05-28       Impact factor: 5.948

6.  Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains?

Authors:  Kyle J Popovich; Robert A Weinstein; Bala Hota
Journal:  Clin Infect Dis       Date:  2008-03-15       Impact factor: 9.079

7.  Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections.

Authors:  Cynthia L Maree; Robert S Daum; Susan Boyle-Vavra; Kelli Matayoshi; Loren G Miller
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

8.  Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005.

Authors:  Eili Klein; David L Smith; Ramanan Laxminarayan
Journal:  Emerg Infect Dis       Date:  2007-12       Impact factor: 6.883

9.  Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care.

Authors:  Linda F McCaig; L Clifford McDonald; Sanjay Mandal; Daniel B Jernigan
Journal:  Emerg Infect Dis       Date:  2006-11       Impact factor: 6.883

10.  Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005.

Authors:  Marya D Zilberberg; Andrew F Shorr; Marin H Kollef
Journal:  Emerg Infect Dis       Date:  2008-11       Impact factor: 6.883

View more
  22 in total

1.  Nasal Carriage of Epidemic Methicillin-Resistant Staphylococcus aureus 15 (EMRSA-15) Clone Observed in Three Chicago-Area Long-Term Care Facilities.

Authors:  Sanchita Das; Christopher J Anderson; Althea Grayes; Katherine Mendoza; Maureen Harazin; Donna M Schora; Lance R Peterson
Journal:  Antimicrob Agents Chemother       Date:  2013-06-24       Impact factor: 5.191

2.  Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.

Authors:  Brian L Cheng; Travis B Nielsen; Paul Pantapalangkoor; Fan Zhao; Jean C Lee; Christopher P Montgomery; Brian Luna; Brad Spellberg; Robert S Daum
Journal:  Hum Vaccin Immunother       Date:  2017-04-19       Impact factor: 3.452

3.  Microbiology: Resistance fighters.

Authors:  Bill Cannon
Journal:  Nature       Date:  2014-05-01       Impact factor: 49.962

Review 4.  Staphylococcus aureus in the Intensive Care Unit: Are These Golden Grapes Ripe for a New Approach?

Authors:  Georgia R Sampedro; Juliane Bubeck Wardenburg
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

5.  Trends in methicillin-resistant Staphylococcus aureus bloodstream infections using statewide population-based surveillance and hospital discharge data, Connecticut, 2010-2018.

Authors:  Ashley N Rose; Paula Clogher; Kelly M Hatfield; Runa H Gokhale; Isaac See; Susan Petit
Journal:  Infect Control Hosp Epidemiol       Date:  2020-06       Impact factor: 3.254

Review 6.  Trends in Community Versus Health Care-Acquired Methicillin-Resistant Staphylococcus aureus Infections.

Authors:  David P Calfee
Journal:  Curr Infect Dis Rep       Date:  2017-11-03       Impact factor: 3.725

7.  The Impact of Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococcus (VRE) Flags on Hospital Operations.

Authors:  Erica S Shenoy; Hang Lee; Taige Hou; Winston Ware; Erin E Ryan; David C Hooper; Rochelle P Walensky
Journal:  Infect Control Hosp Epidemiol       Date:  2016-03-29       Impact factor: 3.254

8.  The licorice pentacyclic triterpenoid component 18β-glycyrrhetinic acid enhances the activity of antibiotics against strains of methicillin-resistant Staphylococcus aureus.

Authors:  A de Breij; T G Karnaoukh; J Schrumpf; P S Hiemstra; P H Nibbering; J T van Dissel; P C de Visser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-15       Impact factor: 3.267

9.  Critical role for the AIM2 inflammasome during acute CNS bacterial infection.

Authors:  Richa Hanamsagar; Amy Aldrich; Tammy Kielian
Journal:  J Neurochem       Date:  2014-02-19       Impact factor: 5.372

10.  Staphylococcal enterotoxin P predicts bacteremia in hospitalized patients colonized with methicillin-resistant Staphylococcus aureus.

Authors:  Michael S Calderwood; Christopher A Desjardins; George Sakoulas; Robert Nicol; Andrea Dubois; Mary L Delaney; Ken Kleinman; Lisa A Cosimi; Michael Feldgarden; Andrew B Onderdonk; Bruce W Birren; Richard Platt; Susan S Huang
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.